Buscar resultados de ensayos clínicos
Mucopolysaccharidosis Type II - 80 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: A Study of JR-141 in Patients With Mucopolysaccharidosis Type II Condición: Mucopolysaccharidosis II Fecha: 2017-04-10 Intervenciones: Drug: JR-141 IV infusion (lyophilized powder), 0.01-2.0 mg/kg/week |
Recruiting |
Nombre del estudio: Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome Condición: Fecha: 2024-05-19 |
Completed |
Nombre del estudio: To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients Condición: Mucopolysaccharidosis II Fecha: 2011-02-22 Intervenciones:
|
Recruiting |
Nombre del estudio: The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients Condición: Hunter Syndrome Fecha: 2014-01-19 |
Recruiting |
Nombre del estudio: Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age Condición: Hunter Syndrome Fecha: 2015-05-20 Intervenciones: Drug: Elaprase for intravenous (IV) infusion Patients enrolled in this study will receive once-weekly IV |
Completed |
Nombre del estudio: Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome Condición: Hunter Syndrome Fecha: 2011-10-06 Intervenciones: Other: No treatment |
Completed |
Nombre del estudio: An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Condición: Hunter Syndrome Fecha: 2009-04-16 Intervenciones: Biological: Idursulfase Patients received idursulfase as prescribed by their physician following locally |
Completed |
Nombre del estudio: Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II) Condición: Mucopolysaccharidosis II Fecha: 2003-09-29 Intervenciones:
|
Completed |
Nombre del estudio: A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® Condición: Hunter Syndrome Fecha: 2009-06-12 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Study of Idursulfase-beta (GC1111) in Hunter Syndrome Condición: Mucopolysaccharidosis II Fecha: 2016-01-17 Intervenciones:
|